Showing results (81-90 of 232) with videos related to
Sort By:
Pageof 24
Journal of Neurology, Neurosurgery, and Psychiatry|December 15, 2022
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapiesAlessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.Haematologica|November 30, 2019
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunctionGijs Kooij, Claudio Derada Troletti, Alessandro Leuti, et al.Neurology|June 8, 2018
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched studyLuca Prosperini, Matteo Lucchini, Shalom Haggiag, et al.Frontiers in Neurology|December 17, 2020
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple SclerosisAntonio Giorgio, Marco Battaglini, Giordano Gentile, et al.Therapeutic Advances in Neurological Disorders|May 23, 2022
Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCERaymond Hupperts, Claudio Gasperini, Jan Lycke, et al.Journal of Neurology|December 12, 2024
Unveiling preferences in multiple sclerosis care: insights from an Italian discrete-choice experiment with patients and healthcare professionalsClaudio Gasperini, Mario Alberto Battaglia, Federica Balzani, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2024
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trialsValeria Pozzilli, Shalom Haggiag, Massimiliano Di Filippo, et al.BMC Neurology|October 15, 2009
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective studyEmilia Sbardella, Valentina Tomassini, Claudio Gasperini, et al.Journal of Neurology|September 10, 2005
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosisValentina Tomassini, Andrea Paolillo, Pierluigi Russo, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2011
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI studyPatrizia Pantano, Silvia Bernardi, Emanuele Tinelli, et al.Pageof 24